Structural basis of Cas3 activation in type I-C CRISPR-Cas system

被引:1
|
作者
Kim, Do Yeon [1 ,2 ]
Lee, So Yeon [1 ,2 ]
Ha, Hyun Ji [1 ]
Park, Hyun Ho [1 ,2 ]
机构
[1] Chung Ang Univ, Coll Pharm, Seoul 06974, South Korea
[2] Chung Ang Univ, Grad Sch, Dept Global Innovat Drugs, Seoul 06974, South Korea
基金
新加坡国家研究基金会;
关键词
PROVIDES ACQUIRED-RESISTANCE; INTERFERENCE; BACTERIA; NUCLEASE; INSIGHTS; IMMUNITY; HELICASE; TOOL;
D O I
10.1093/nar/gkae723
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
CRISPR-Cas systems function as adaptive immune mechanisms in bacteria and archaea and offer protection against phages and other mobile genetic elements. Among many types of CRISPR-Cas systems, Type I CRISPR-Cas systems are most abundant, with target interference depending on a multi-subunit, RNA-guided complex known as Cascade that recruits a transacting helicase nuclease, Cas3, to degrade the target. While structural studies on several other types of Cas3 have been conducted long ago, it was only recently that the structural study of Type I-C Cas3 in complex with Cascade was revealed, shedding light on how Cas3 achieve its activity in the Cascade complex. In the present study, we elucidated the first structure of standalone Type I-C Cas3 from Neisseria lactamica (NlaCas3). Structural analysis revealed that the histidine-aspartate (HD) nuclease active site of NlaCas3 was bound to two Fe2+ ions that inhibited its activity. Moreover, NlaCas3 could cleave both single-stranded and double-stranded DNA in the presence of Ni2+ or Co2+, showing the highest activity in the presence of both Ni2+ and Mg2+ ions. By comparing the structural studies of various Cas3 proteins, we determined that our NlaCas3 stays in an inactive conformation, allowing us to understand the structural changes associated with its activation and their implication. Graphical Abstract
引用
收藏
页码:10563 / 10574
页数:12
相关论文
共 50 条
  • [21] Research Progress on the Mechanism and Application of the Type I CRISPR-Cas System
    Yang, Peihong
    Zhang, Shuai
    Hu, Debao
    Li, Xin
    Guo, Yiwen
    Guo, Hong
    Zhang, Linlin
    Ding, Xiangbin
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (23)
  • [22] Distinct Subcellular Localization of a Type I CRISPR Complex and the Cas3 Nuclease in Bacteria
    Govindarajan, Sutharsan
    Borges, Adair
    Karambelkar, Shweta
    Bondy-Denomy, Joseph
    JOURNAL OF BACTERIOLOGY, 2022, 204 (05)
  • [23] The structural biology of type III CRISPR-Cas systems
    Li, Xuzichao
    Han, Jie
    Yang, Jie
    Zhang, Heng
    JOURNAL OF STRUCTURAL BIOLOGY, 2024, 216 (01)
  • [24] Characterization and applications of Type I CRISPR-Cas systems
    Hidalgo-Cantabrana, Claudio
    Barrangou, Rodolphe
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2020, 48 (01) : 15 - 23
  • [25] Cas3 is a limiting factor for CRISPR-Cas immunity in Escherichia coli cells lacking H-NS
    Majsec, Kristina
    Bolt, Edward L.
    Ivancic-Bace, Ivana
    BMC MICROBIOLOGY, 2016, 16
  • [26] Structural insights into the inactivation of the type I-F CRISPR-Cas system by anti-CRISPR proteins
    Yang, Lingguang
    Zhang, Yi
    Yin, Peipei
    Feng, Yue
    RNA BIOLOGY, 2021, 18 : 562 - 573
  • [27] The CRISPR-Cas system in Enterobacteriaceae
    Medina-Aparicio, Liliana
    Davila, Sonia
    Rebollar-Flores, Javier E.
    Calva, Edmundo
    Hernandez-Lucas, Ismael
    PATHOGENS AND DISEASE, 2018, 76 (01):
  • [28] Structural features of Cas2 from Thermococcus onnurineus in CRISPR-cas system type IV
    Jung, Tae-Yang
    Park, Kwang-Hyun
    An, Yan
    Schulga, Alexy
    Deyev, Sergey
    Jung, Jong-Hyun
    Woo, Eui-Jeon
    PROTEIN SCIENCE, 2016, 25 (10) : 1890 - 1897
  • [29] Structural basis for inhibition of an archaeal CRISPR-Cas type I-D large subunit by an anti-CRISPR protein
    Manav, M. Cemre
    Van, Lan B.
    Lin, Jinzhong
    Fuglsang, Anders
    Peng, Xu
    Brodersen, Ditlev E.
    NATURE COMMUNICATIONS, 2020, 11 (01)
  • [30] Functional Identification of the Xanthomonas oryzae pv. oryzae Type I-C CRISPR-Cas System and Its Potential in Gene Editing Application
    Liu, Qibing
    Wang, Siwei
    Long, Juying
    Chen, Zhuoyue
    Yang, Bing
    Lin, Fei
    FRONTIERS IN MICROBIOLOGY, 2021, 12